Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2010) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacology and Therapeutics | journal | 3.872 Q1 | 233 | 103 | 307 | 22992 | 3285 | 304 | 9.97 | 223.22 |  |
| 2 | Open Neuropsychopharmacology Journal | journal | 0.173 Q3 | 6 | 1 | 12 | 203 | 4 | 11 | 0.33 | 203.00 |  |
| 3 | Antibiotics | journal | 77 | 1 | 0 | 140 | 0 | 0 | 0.00 | 140.00 |  | |
| 4 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.156 Q1 | 52 | 20 | 72 | 2718 | 221 | 72 | 3.12 | 135.90 |  |
| 5 | Drug Resistance Updates | journal | 5.328 Q1 | 132 | 19 | 49 | 2423 | 644 | 49 | 13.41 | 127.53 | |
| 6 | Recent Patents on CNS Drug Discovery | journal | 0.886 Q2 | 36 | 22 | 64 | 2758 | 190 | 64 | 2.88 | 125.36 | |
| 7 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 21 | 65 | 2577 | 133 | 65 | 1.91 | 122.71 | | |
| 8 | Drug Metabolism Reviews | journal | 1.371 Q1 | 108 | 39 | 93 | 4582 | 469 | 88 | 4.58 | 117.49 | |
| 9 | Current Neuropharmacology | journal | 1.271 Q1 | 103 | 41 | 88 | 4630 | 324 | 85 | 3.46 | 112.93 | |
| 10 | Expert Opinion on Emerging Drugs | journal | 0.984 Q1 | 54 | 47 | 133 | 4968 | 471 | 133 | 3.91 | 105.70 |  |
| 11 | Current Signal Transduction Therapy | journal | 0.202 Q3 | 22 | 25 | 69 | 2559 | 40 | 69 | 0.75 | 102.36 | |
| 12 | Neurotherapeutics | journal | 2.320 Q1 | 136 | 53 | 220 | 4993 | 1477 | 206 | 6.90 | 94.21 | |
| 13 | Expert Review of Clinical Pharmacology | journal | 0.218 Q3 | 60 | 68 | 129 | 5932 | 95 | 110 | 0.74 | 87.24 | |
| 14 | CNS Drugs | journal | 1.518 Q1 | 129 | 74 | 245 | 6444 | 1307 | 226 | 5.64 | 87.08 | |
| 15 | HIV Therapy | journal | 0.260 Q3 | 14 | 48 | 60 | 4159 | 25 | 42 | 0.42 | 86.65 | |
| 16 | CNS Neuroscience and Therapeutics | journal | 1.013 Q1 | 91 | 52 | 66 | 4399 | 258 | 63 | 3.91 | 84.60 | |
| 17 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 29 | 82 | 2446 | 144 | 82 | 2.09 | 84.34 | | |
| 18 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.531 Q2 | 30 | 27 | 79 | 2260 | 145 | 79 | 1.40 | 83.70 | |
| 19 | Expert Review of Neurotherapeutics | journal | 0.956 Q1 | 98 | 173 | 500 | 14424 | 1466 | 439 | 3.24 | 83.38 | |
| 20 | PPAR Research | journal | 1.176 Q1 | 59 | 59 | 196 | 4684 | 539 | 183 | 2.56 | 79.39 | |
| 21 | Expert Opinion on Investigational Drugs | journal | 1.367 Q1 | 117 | 149 | 508 | 11809 | 2156 | 487 | 4.39 | 79.26 | |
| 22 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 32 | 75 | 2531 | 198 | 75 | 2.60 | 79.09 | | |
| 23 | Drugs | journal | 1.357 Q1 | 188 | 152 | 555 | 11865 | 2685 | 485 | 4.81 | 78.06 | |
| 24 | Journal of International Peacekeeping | journal | 0.137 Q3 | 14 | 18 | 49 | 1393 | 13 | 46 | 0.48 | 77.39 | |
| 25 | OncoTargets and Therapy | journal | 0.243 Q3 | 86 | 22 | 23 | 1666 | 7 | 23 | 0.30 | 75.73 |  |
| 26 | Clinical Pharmacokinetics | journal | 1.533 Q1 | 184 | 58 | 190 | 4333 | 1017 | 177 | 5.30 | 74.71 | |
| 27 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 7 | 4 | 518 | 0 | 4 | 0.00 | 74.00 | | |
| 28 | Expert Opinion on Drug Safety | journal | 0.857 Q2 | 90 | 83 | 220 | 5823 | 666 | 190 | 2.91 | 70.16 | |
| 29 | Paediatric Drugs | journal | 0.566 Q2 | 70 | 39 | 152 | 2733 | 290 | 126 | 1.78 | 70.08 | |
| 30 | Expert Review of Anticancer Therapy | journal | 1.166 Q1 | 85 | 191 | 519 | 13288 | 1486 | 465 | 3.06 | 69.57 | |
| 31 | Expert Opinion on Pharmacotherapy | journal | 0.660 Q2 | 93 | 282 | 839 | 19205 | 2183 | 815 | 2.68 | 68.10 | |
| 32 | Orphanet Journal of Rare Diseases | journal | 2.290 Q1 | 136 | 41 | 113 | 2782 | 975 | 113 | 7.51 | 67.85 | |
| 33 | Drugs and Aging | journal | 1.100 Q1 | 109 | 82 | 251 | 5532 | 854 | 245 | 3.43 | 67.46 | |
| 34 | Biologics: Targets and Therapy | journal | 0.396 Q2 | 47 | 11 | 186 | 737 | 288 | 183 | 1.86 | 67.00 | |
| 35 | Current Drug Therapy | journal | 0.171 Q3 | 20 | 37 | 77 | 2475 | 50 | 74 | 0.66 | 66.89 | |
| 36 | Drugs of the Future | journal | 0.218 Q3 | 46 | 113 | 350 | 7369 | 195 | 349 | 0.53 | 65.21 |  |
| 37 | BioDrugs | journal | 1.664 Q1 | 79 | 47 | 119 | 2941 | 576 | 111 | 5.36 | 62.57 | |
| 38 | Cochrane Database of Systematic Reviews | journal | 1.478 Q1 | 327 | 677 | 3444 | 41856 | 13977 | 3444 | 3.65 | 61.83 | |
| 39 | AIDS Reviews | journal | 1.964 Q1 | 62 | 29 | 74 | 1790 | 362 | 67 | 4.90 | 61.72 | |
| 40 | European Neuropsychopharmacology | journal | 1.692 Q1 | 130 | 95 | 332 | 5527 | 1462 | 326 | 4.43 | 58.18 | |
| 41 | Therapeutic Advances in Cardiovascular Disease | journal | 0.684 Q2 | 41 | 34 | 98 | 1972 | 257 | 90 | 2.60 | 58.00 | |
| 42 | Therapeutics and Clinical Risk Management | journal | 0.586 Q2 | 70 | 18 | 373 | 1038 | 789 | 365 | 2.19 | 57.67 | |
| 43 | Targeted Oncology | journal | 0.633 Q2 | 59 | 34 | 93 | 1929 | 150 | 82 | 2.16 | 56.74 |  |
| 44 | Therapeutic Advances in Respiratory Disease | journal | 0.709 Q2 | 50 | 32 | 78 | 1805 | 191 | 75 | 2.37 | 56.41 | |
| 45 | Cardiovascular Therapeutics | journal | 0.996 Q1 | 54 | 59 | 69 | 3319 | 171 | 63 | 2.48 | 56.25 | |
| 46 | Current Drug Safety | journal | 0.508 Q2 | 41 | 50 | 92 | 2717 | 200 | 86 | 2.29 | 54.34 | |
| 47 | Experimental and Clinical Psychopharmacology | journal | 1.313 Q1 | 101 | 58 | 165 | 3134 | 524 | 165 | 2.87 | 54.03 | |
| 48 | Vascular Health and Risk Management | journal | 0.704 Q2 | 82 | 114 | 384 | 6145 | 1095 | 381 | 2.99 | 53.90 | |
| 49 | Pulmonary Pharmacology and Therapeutics | journal | 0.889 Q2 | 81 | 67 | 311 | 3601 | 800 | 298 | 2.54 | 53.75 | |
| 50 | Cancer and Chemotherapy Reviews | journal | 0.102 Q4 | 4 | 19 | 54 | 999 | 3 | 54 | 0.09 | 52.58 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data